Skip to content

In the BioHarmony Drug Report Database

Clascoterone

Winlevi (clascoterone) is a small molecule pharmaceutical. Clascoterone was first approved as Winlevi on 2020-08-26. The pharmaceutical is active against androgen receptor. Winlevi's patents are valid until 2030-07-25 (FDA).
Trade Name Winlevi
Common Name Clascoterone
Indication
Drug Class Antiandrogens
Clascoterone
Get full access now